Natixis’s NuVasive, Inc. NUVA Stock Holding History

Natixis’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-188,209	Closed	-$7.83M	–	1166
2023 Q2	$7.83M	Sell	188,209 -76,625	-29%	-$3.15M	0.06%	240
2023 Q1	$10.9M	Buy	264,834 +263,174	+15,854%	+$11.3M	0.1%	181
2022 Q4	$68.5K	Buy	+1,660	New	+$67.2K	﹤0.01%	900
2019 Q4	–	Sell	-7,466	Closed	-$473K	–	987
2019 Q3	$473K	Sell	7,466 -16,903	-69%	-$1.06M	﹤0.01%	685
2019 Q2	$1.43M	Buy	+24,369	New	+$1.44M	0.01%	489
2018 Q2	–	Sell	-4,042	Closed	-$211K	–	1014
2018 Q1	$211K	Sell	4,042 -85	-2%	-$4.31K	﹤0.01%	835
2017 Q4	$241K	Sell	4,127 -17,101	-81%	-$970K	﹤0.01%	740
2017 Q3	$1.18M	Buy	+21,228	New	+$1.4M	0.01%	495
2017 Q2	–	Sell	-9,846	Closed	-$735K	–	1014
2017 Q1	$735K	Buy	9,846 +5,984	+155%	+$434K	0.01%	449
2016 Q4	$260K	Buy	+3,862	New	+$249K	﹤0.01%	698

Other funds holding NUVA

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Natixis's NUVA Position: Q3 2023 in Review

Natixis sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 188,209 shares — an estimated $7.83M sold.

Natixis first reported a position in NUVA in Q4 2016 and held it in 10 quarters. The position peaked at $10.9M in Q1 2023. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

Natixis reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
Natixis sold 188,209 NuVasive, Inc. shares in Q3 2023, an estimated $7.83M.
Natixis first reported a position in NuVasive, Inc. in Q4 2016 and held it in 10 quarters.
Natixis's NuVasive, Inc. position peaked at $10.9M in Q1 2023.
2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Natixis's 13F filing for Q3 2023, filed 14 Nov 2023.